Business Context and Reporting Period
Company: Pavmed Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 17, 2020
Reporting Period: Event-based report regarding index inclusion announcement.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to disclose a corporate event regarding index inclusion.
Material Changes
Index Inclusion: Pavmed Inc. announced its selection for inclusion in the Russell 2000 Index and the Russell 3000 Index. This change is effective after the U.S. market open on June 29, 2020, as part of the annual reconstitution.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) confirming the index addition based on a preliminary list from FTSE Russell.
Regulatory Note: Information under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference except as expressly stated.
Emerging Growth Company: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the final inclusion of PAVM in the Russell 2000 and Russell 3000 indexes effective June 29, 2020.
- Review the attached press release (Exhibit 99.1) for additional details on the announcement.
- Confirm trading symbols: Common Stock (PAVM), Series Z Warrants (PAVMZ), and Series W Warrants (PAVMW) on The Nasdaq Stock Market LLC.
- Note that no financial performance data is provided in this specific 8-K filing.